Long-term outcome after neuroleptic malignant syndrome.
Little information is available on long-term outcome after neuroleptic malignant syndrome (NMS). Four patients are described who had survived episodes of NMS 2 to 11 years earlier. Some were safely re-treated with neuroleptics, and all safely received general anesthesia. No major sequelae were identified. Recommendations for management of patients after NMS are provided.
D000328:Adult; D000768:Anesthesia, General / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis* / Q000628:therapy; D010043:Outcome and Process Assessment, Health Care
D014150:Antipsychotic Agents; D003402:Creatine Kinase